Scott Coleman

Title: Scott Coleman: Innovator in Polymyxin Compounds

Introduction

Scott Coleman is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his work on polymyxin compounds. His innovative approach has led to advancements in the treatment of microbial infections.

Latest Patents

Scott Coleman holds a patent for polymyxin compounds, which includes a compound of formula (I) along with its salts, solvates, and protected forms. This invention also encompasses pharmaceutical compositions that utilize these compounds and outlines their application in methods of treatment for microbial infections. The compounds of formula (I) are represented in a specific structural format, showcasing the complexity and utility of his work.

Career Highlights

Scott Coleman is currently associated with Spero Therapeutics, Inc., where he continues to push the boundaries of pharmaceutical innovation. His dedication to research and development has positioned him as a key player in the industry, contributing to the advancement of medical treatments.

Collaborations

Some of his notable coworkers include Pamela Brown and Michael Dawson. Their collaborative efforts have further enhanced the research environment at Spero Therapeutics, Inc., fostering innovation and creativity.

Conclusion

Scott Coleman's work in polymyxin compounds exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions are paving the way for new treatments that address critical health challenges.